<!DOCTYPE html>
<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8"> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9"> <![endif]-->
<!--[if IE ]> <html class="no-js IE"> <![endif]-->
<!--[if IE ]> <html class="no-js IE"> <![endif]-->
<!--[if gt IE 8]><!--> <html class="no-js"> <!--<![endif]-->
    <head>
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <title></title>
        <meta name="description" content="">
        <meta name="viewport" content="width=device-width, initial-scale=1">
        <link rel="stylesheet" href="css/styles.css">
        <link rel="stylesheet" href="css/customStyles.css">
    </head>
    <body class="about">
        <div id="header">
            <div class="header agilvaxLogoSmallScreen center">
                <a href="index.html"><img src="images/agilvaxHeaderLogo.png" alt="Agilvax" title="Agilvax" width="135"></a>
            </div>

            <div class="navigation">
                    <div class="mobileNavToggle">Menu</div>
                    <div class="navigationBar">
                        <ul class="nav navLeft">
                        </ul><!-- /nav -->
                        <ul class="nav navRight">
                        </ul><!-- /nav -->
                    </div><!-- /navigationBar -->
            </div><!-- /navigation -->
        </div><!-- #header -->

        <div class="pageTitle">
            <div class="containerNarrow">
                <h1 class="slideInBT">About Agilvax</h1>
            </div>
        </div><!-- /pageTitle -->
        <div class="mainContent">
            <div class="containerNarrow">
                <div class="intro">
                    <p>Agilvax is a private company that discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases.</p>
                </div><!-- /intro -->
                
                <p>Agilvax is able to rapidly identify and select lead immunotherapy candidates through the power of the body’s own immune system in combination with Agilvax’s proprietary Virus Like Particle (VLP) platform technology.</p>
                <p>Agilvax optimizes lead immunotherapy candidates through an extensive in vitro and in vivo testing process to ensure clinical efficacy. Immunotherapies with demonstrated clinical effectiveness are brought forward through pre-clinical and clinical testing. This process results in the development of effective and robust immunotherapies and vaccines that represent attractive out-licensing opportunities for Pharmaceutical and (or) Biotechnology partners.</p>
                <p>Agilvax actively pursues and welcomes collaborations and partnerships with industry, academia, and government institutions.</p>


                <div class="clear"></div>

                <div class="intro">
                    <p>Agilvax's lead asset is AX09 immunotherapy candidate for the treatment of aggressive forms of breast cancer. Immunization with AX09 elicits antibodies targeting breast cancer stem cells, a key cellular reservoir for relapse, metastatic progression and therapeutic resistance.</p>
                </div>
            </div><!-- /containerNarrow -->
        </div><!-- /MainContent -->
       


        <div id="footer">
        </div><!-- /footer -->

        <script src="http://ajax.googleapis.com/ajax/libs/jquery/1.10.2/jquery.min.js"></script>
        <script src="http://ajax.googleapis.com/ajax/libs/jqueryui/1.10.4/jquery-ui.min.js"></script>
        <script src="js/modernizr-2.6.2.min.js"></script>
        <script src="js/plugins.js"></script>

        <!-- LoadIncludes -->
        <script>
            $( ".navLeft" ).load( "includes/nav.html" );
            $( ".navRight" ).load( "includes/navRight.html" );
            $( "#footer" ).load( "includes/footer.html" );
        </script>
        <script src="js/main.js"></script>

    </body>
</html>
